Skin metabolomic profile in persistent inflammation of multifactorial origin

Authors

DOI:

https://doi.org/10.70577/jpy09g33

Keywords:

skin metabolomics, persistent inflammation, epidermal barrier, dysbiosis, immunometabolism, dermatology

Abstract

The study examines persistent cutaneous inflammation of multifactorial origin, characterized by the interaction between epidermal barrier dysfunction, metabolomic alterations, microbial dysbiosis, and sustained immune activation. The objective was to analyze the skin metabolomic profile and its relationship with biophysical, immunological, and microbiological variables. A quantitative approach with a non-experimental, descriptive-explanatory design was applied, based on the review of reports from international organizations and scientific literature (2021–2023), using Pearson correlation, multiple linear regression, Cronbach’s alpha, and Shapiro–Wilk test. The results revealed a differential metabolomic signature among healthy, non-lesional, and lesional skin, highlighting alterations in lipids and amino acids; a significant inverse relationship was identified between transepidermal water loss and skin hydration, as well as a direct association between cutaneous dysbiosis, predominance of Staphylococcus aureus, and clinical severity; additionally, activation of the NAD+/NAMPT/PARP1 axis was identified as a central mechanism in persistent inflammation, along with the capacity of targeted therapies to restore epidermal functionality. It is established that the skin metabolomic profile constitutes an integrative axis for understanding persistent inflammation and guiding precision medicine strategies in dermatology.

Downloads

Download data is not yet available.

References

Amat-Samaranch, V., & Silvestre Salvador, J. F. (2023). Haptens, proteins, and atopic dermatitis. Actas Dermo-Sifiliográficas, 114(4), T308–T317. https://doi.org/10.1016/j.ad.2023.02.011

Arroyo, A. B., Bernal-Carrión, M., Cantón-Sandoval, J., Cabas, I., Corbalán-Vélez, R., Martínez-Menchón, T., Ferri, B., Cayuela, M. L., García-Moreno, D., & Mulero, V. (2023). NAMPT and PARylation are involved in the pathogenesis of atopic dermatitis. International Journal of Molecular Sciences, 24(9), 7992. https://doi.org/10.3390/ijms24097992

Becerra-Becerra, Y., Gómez-Moyano, E., & Martínez-Pérez, M. (2023). Avances en el estudio metabolómico de enfermedades inflamatorias cutáneas. Revista Latinoamericana de Dermatología, 41(2), 85–97. https://doi.org/10.1016/j.rld.2023.02.005

Carmona-Cruz, S., Orozco-Covarrubias, L., & Sáez-de-Ocariz, M. (2022). The human skin microbiome in selected cutaneous diseases. Frontiers in Cellular and Infection Microbiology, 12, 834135. https://doi.org/10.3389/fcimb.2022.834135

Carrascosa, J. M., Puig, L., Belinchón Romero, I., Salgado-Boquete, L., Del Alcázar, E., Andrés Lencina, J. J., Moreno, D., & de la Cueva, P. (2022). Practical update of the recommendations published by the Psoriasis Group of the Spanish Academy of Dermatology and Venereology (GPS) on the treatment of psoriasis with biologic therapy. Part 1. Concepts and general management of psoriasis with biologic therapy. Actas Dermo-Sifiliográficas, 113(3), 261–277. https://doi.org/10.1016/j.ad.2021.10.003

Castillo-González, R., Fernández-Delgado, I., & Comberiati, P. (2022). Bacteriotherapy with human skin commensals in atopic dermatitis. Allergy, 77(4), 1331–1333. https://doi.org/10.1111/all.15162

Fernández-Gallego, N., Castillo-González, R., Méndez-Barbero, N., López-Sanz, C., Obeso, D., Villaseñor, A., Escribese, M. M., López-Melgar, B., Salamanca, J., Benedicto-Buendía, A., Jiménez-Borreguero, L. J., Ibañez, B., Sastre, J., Belver, M. T., Vega, F., Blanco, C., Barber, D., Sánchez-Madrid, F., de la Fuente, H., Martín, P., Esteban, V., & Jiménez-Saiz, R. (2022). The impact of type 2 immunity and allergic diseases in atherosclerosis. Allergy, 77(11), 3249–3266. https://doi.org/10.1111/all.15426

Ilves, T., Harvima, I. T., & Peltonen, S. (2021). Skin metabolomics and inflammatory skin diseases: Current perspectives. Acta Dermato-Venereologica, 101(10), adv00567. https://doi.org/10.2340/00015555-3766

Khadka, V. D., Key, F. M., Romo-González, C., Martínez-Gayosso, A., Campos-Cabrera, B. L., Gerónimo-Gallegos, A., Lynn, T. C., Durán-McKinster, C., Coria-Jiménez, R., Lieberman, T. D., & García-Romero, M. T. (2021). The skin microbiome of patients with atopic dermatitis normalizes gradually during treatment. Frontiers in Cellular and Infection Microbiology, 11, 720674. https://doi.org/10.3389/fcimb.2021.720674

Leyva-Castillo, J. M., Abdelhamid, M., Shirey, M., Sun, J., Thomas, J. M., Ikediobi, O., Trempus, C., McGurk, A., & Arbiser, J. L. (2023b). Ant venom-based ceramide therapy is effective against atopic dermatitis and psoriasis. Journal of Drugs in Dermatology, 22(10), 1001–1006. https://doi.org/10.36849/JDD.7308

Leyva-Castillo, J.-M., McGurk, A., Strakosha, M., Vega-Mendoza, D., Smith, S. E., Stafstrom, K., Elkins, M., Chou, J., Wang, Y.-H., & Geha, R. S. (2023a). IL-4 receptor alpha blockade dampens allergic inflammation and upregulates IL-17A expression to promote S. aureus clearance in antigen sensitized mouse skin. Journal of Allergy and Clinical Immunology, 152(4), 907–915. https://doi.org/10.1016/j.jaci.2023.05.025

Martínez-Morcillo, F. J., Cantón-Sandoval, J., Martínez-Menchón, T., Corbalán-Vélez, R., Mesa-Del-Castillo, P., Pérez-Oliva, A. B., García-Moreno, D., & Mulero, V. (2021a). Non-canonical roles of NAMPT and PARP in inflammation. Developmental and Comparative Immunology, 115, 103881. https://doi.org/10.1016/j.dci.2020.103881

Martínez-Morcillo, F. J., Cantón-Sandoval, J., Martínez-Navarro, F. J., Cabas, I., Martínez-Vicente, I., Armistead, J., Hatzold, J., López-Muñoz, A., Martínez-Menchón, T., Corbalán-Vélez, R., Pérez-Oliva, A. B., Mesa-Del-Castillo, P., García-Moreno, D., & Mulero, V. (2021b). NAMPT-derived NAD+ fuels PARP1 to promote skin inflammation through parthanatos cell death. PLoS Biology, 19(10), e3001455. https://doi.org/10.1371/journal.pbio.3001455

Montero-Vílchez, T., Cuenca-Barrales, C., Rodríguez-Pozo, J.-A., Díaz-Calvillo, P., Tercedor-Sánchez, J., Martínez-López, A., Molina-Leyva, A., & Arias-Santiago, S. (2022a). Epidermal barrier function and skin homeostasis in atopic dermatitis: The impact of age. Life, 12(1), 132. https://doi.org/10.3390/life12010132

Montero-Vílchez, T., Rodríguez-Pozo, J.-A., Díaz-Calvillo, P., Salazar-Nievas, M., Tercedor-Sánchez, J., Molina-Leyva, A., & Arias-Santiago, S. (2022b). Dupilumab improves skin barrier function in adults with atopic dermatitis: A prospective observational study. Journal of Clinical Medicine, 11(12), 3341. https://doi.org/10.3390/jcm11123341

Montero-Vílchez, T., Sanabria-de-la-Torre, R., Sánchez-Díaz, M., Ureña-Paniego, C., Molina-Leyva, A., & Arias-Santiago, S. (2023). The impact of dupilumab on skin barrier function: A systematic review. Journal of the European Academy of Dermatology and Venereology, 37(7), 1284–1292. https://doi.org/10.1111/jdv.19081

Montero-Vílchez, T., Segura-Fernández-Nogueras, M. V., Pérez-Rodríguez, I., Soler-Gongora, M., Martínez-López, A., Fernández-González, A., Molina-Leyva, A., & Arias-Santiago, S. (2021). Skin barrier function in psoriasis and atopic dermatitis: Transepidermal water loss and temperature as useful tools to assess disease severity. Journal of Clinical Medicine, 10(2), 359. https://doi.org/10.3390/jcm10020359

Paganelli, A., Rinaldi, F., & Giacomoni, P. (2022). Metabolomics in dermatology: Advances and perspectives. International Journal of Molecular Sciences, 23(17), 9876. https://doi.org/10.3390/ijms23179876

Downloads

Published

2025-02-03

How to Cite

Skin metabolomic profile in persistent inflammation of multifactorial origin. (2025). Salud Y Expectativas , 3(1), 19-37. https://doi.org/10.70577/jpy09g33

Similar Articles

You may also start an advanced similarity search for this article.